Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of difluprednate beta form crystal

A technology of difluprednate and crystal form, which is applied in the field of preparation of difluprednate crystal form β, can solve problems such as crystal form instability, and achieve the effects of stable impurities, high yield, and simple preparation process

Active Publication Date: 2016-05-25
CHINA RESOURCES ZIZHU PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The crystalline form α of difluprednate is obtained by crystallization with conventional low-toxicity solvents such as methanol, ethyl acetate, acetone, ethanol, etc., which is unstable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of difluprednate beta form crystal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Add 10 g of difluprednate and 80 ml of absolute ethanol to the reaction flask, heat to 75-80° C. to dissolve, and filter. Transfer the filtrate and the precipitated solids to a one-necked bottle, heat in a water bath at 60°C and concentrate by rotary evaporation until the remaining volume is about 50ml, then reheat to reflux to dissolve. Cool down and crystallize at a rate of 0.5°C / min. Stir at -10°C for 30 minutes, filter, and dry in the air to obtain the crystal form β of difluprednate. Yield 92%, purity 99%.

Embodiment 2

[0023] Add 10 g of difluprednate and 40 ml of absolute ethanol to the reaction flask, heat to 75-80° C. to dissolve, and filter. Transfer the filtrate and the precipitated solids to a one-necked bottle, heat in a water bath at 55°C and concentrate by rotary evaporation until the remaining volume is about 45ml, then reheat to reflux to dissolve. Cool down and crystallize at a rate of 0.3°C / min. Stir at -10°C for 30 minutes, filter, and dry in the air to obtain the crystal form β of difluprednate. Yield 91.5%, purity 99.1%.

Embodiment 3

[0025] Add 10 g of difluprednate and 100 ml of absolute ethanol to the reaction flask, heat to 75-80° C. to dissolve, and filter. Transfer the filtrate and the precipitated solid into a one-necked bottle, heat and concentrate in a water bath at 65°C by rotary evaporation until the remaining volume is about 55ml, and reheat to reflux to dissolve. Cool down at a rate of 2°C / min for crystallization. Stir at -10°C for 30 minutes, filter, and dry in the air to obtain the crystal form β of difluprednate. Yield 91%, purity 98.5%

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of difluprednate beta form crystal. In the preparation method, absolute ethyl alcohol is taken as a solvent to prepare difluprednate beta form crystal. The preparation method is simple and economical, and is high in yield; the prepared difluprednate beta form crystal is stable and contains less impurity; and the preparation method is suitable for industrialized mass production.

Description

technical field [0001] The invention relates to a preparation method of difluprednate crystal form β, belonging to the field of medicinal chemistry. Background technique [0002] Difluprednate is a glucocorticoid receptor agonist and a fluorinated derivative of prednisolone, which has anti-inflammatory activity and is mainly used in the treatment of postoperative ocular infection and pain. [0003] The crystal forms of difluprednate that have been reported so far include α crystal form, β crystal form and γ crystal form, among which the most stable is the β crystal form. [0004] "Difuprednate: Morethanmeetstheeye" in "Journal of Pharmaceutical and Biomedical Analysis" by GarlottaGiacobe et al. in 2015 disclosed a method for preparing difluprednate crystalline form β by crystallization from acetonitrile. According to the classification of ICHQ3C and the technical guidelines for the study of residual solvents in chemical drugs, acetonitrile belongs to the second-class solven...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07J5/00
Inventor 李志峰蒋彬孙玉霞赵红欣
Owner CHINA RESOURCES ZIZHU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com